Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 382

    1.

    Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men.

    Rask E, Olsson T, Söderberg S, Johnson O, Seckl J, Holst JJ, Ahrén B; Northern Sweden Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA).

    Diabetes Care. 2001 Sep;24(9):1640-5.PMID: 11522713 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.

    J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13.PMID: 12788877 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.

    Rask E, Olsson T, Söderberg S, Holst Jj J, Tura A, Pacini G, Ahrén B.

    Metabolism. 2004 May;53(5):624-31.PMID: 15131768 [PubMed - indexed for MEDLINE]Related articles

    4.

    The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.

    Verdich C, Toubro S, Buemann B, Lysgård Madsen J, Juul Holst J, Astrup A.

    Int J Obes Relat Metab Disord. 2001 Aug;25(8):1206-14.PMID: 11477506 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.

    Lee A, Patrick P, Wishart J, Horowitz M, Morley JE.

    Diabetes Obes Metab. 2002 Sep;4(5):329-35.PMID: 12190996 [PubMed - indexed for MEDLINE]Related articles

    6.

    Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.

    Schou JH, Pilgaard K, Vilsbøll T, Jensen CB, Deacon CF, Holst JJ, Vølund A, Madsbad S, Vaag AA.

    J Clin Endocrinol Metab. 2005 Aug;90(8):4912-9. Epub 2005 May 17.PMID: 15899957 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.

    Vilsbøll T, Krarup T, Madsbad S, Holst JJ.

    Regul Pept. 2003 Jul 15;114(2-3):115-21.PMID: 12832099 [PubMed - indexed for MEDLINE]Related articles

    8.

    Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.

    Svendsen PF, Nilas L, Madsbad S, Holst JJ.

    Metabolism. 2009 May;58(5):586-93.PMID: 19375579 [PubMed - indexed for MEDLINE]Related articles

    9.

    Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

    Vilsbøll T, Krarup T, Deacon CF, Madsbad S, Holst JJ.

    Diabetes. 2001 Mar;50(3):609-13.PMID: 11246881 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.

    Nauck MA, El-Ouaghlidi A, Gabrys B, Hücking K, Holst JJ, Deacon CF, Gallwitz B, Schmidt WE, Meier JJ.

    Regul Pept. 2004 Nov 15;122(3):209-17.PMID: 15491793 [PubMed - indexed for MEDLINE]Related articles

    12.

    Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients.

    Damci T, Yalin S, Balci H, Osar Z, Korugan U, Ozyazar M, Ilkova H.

    Diabetes Care. 2004 May;27(5):1077-80.PMID: 15111524 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

    Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W.

    J Clin Invest. 1993 Jan;91(1):301-7.PMID: 8423228 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs.

    Deacon CF, Wamberg S, Bie P, Hughes TE, Holst JJ.

    J Endocrinol. 2002 Feb;172(2):355-62.PMID: 11834453 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.

    Meier JJ, Kemmeries G, Holst JJ, Nauck MA.

    Diabetes. 2005 Jul;54(7):2212-8.PMID: 15983224 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes.

    Thomsen C, Storm H, Holst JJ, Hermansen K.

    Am J Clin Nutr. 2003 Mar;77(3):605-11.PMID: 12600850 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Postprandial hormone and metabolic responses in simulated shift work.

    Hampton SM, Morgan LM, Lawrence N, Anastasiadou T, Norris F, Deacon S, Ribeiro D, Arendt J.

    J Endocrinol. 1996 Nov;151(2):259-67.PMID: 8958786 [PubMed - indexed for MEDLINE]Related articles

    19.

    Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.

    Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK, Holst JJ.

    J Clin Endocrinol Metab. 2001 Aug;86(8):3717-23.PMID: 11502801 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.